The term 'opportunistic' is used where a smear is collected without a planned or organized system ofcall and recall, and results from the occasion of a woman presenting herself for another medical purpose or getting her to respond through a convenience of situation, such as a workplace test. Or there is a truly opportunistic one, where the facility is presented without prior booking other than general publicity, such as at a Mobile Clinic parked at a convenient place and time. Table 1 gives a list of such 'occasions', and it will be seen that some of these are Health Service generated, such as the gynaecological, family planning, ante-and post-natal and Well Woman clinics. To these must be added the genitourinary medical clinics, which cater for a substantial number of the more 'atrisk' cases where it would be folly not to collect smears. One must realize that the cervical smear is also a pathology test, just like a blood count, and should not be restricted to screening alone or considered as such. There is a fallacy that only symptomless cases should be smeared, and that anyone with a sign or symptom should be refused a smear and referred directly to a gynaecologist. This will rapidly swamp that service, and in any event even the colposcope misses about 25% of the smaller lesions' and does nothing for lesions in the cervical canal or endometrial cavity to which the smear might alert the gynaecologist.
One only has to look at the reason for the failure of the UK screening programme over the past 20 years to learn where we went wrong, but also knowing our population we may still be missing out with our present policy.
The Northern European countries, Finland, Iceland and Sweden, have all had screening programmes of women between the ages of 25-65 years, by formal invitation at 2, 3 or 5-yearly intervals, and have achieved 70% falls in their overall mortality, mainly by virtue of their complete coverage of population, and a remarkable degree of response of between 80 and 90%, to the authority's call to be tested. The UK programme over the same period, with the same number of smears and cost per head of female population, had an overall mortality rate drop of only 13% and the disturbing finding that of every hundred women dying of cervical cancer only 10 had ever had a smear-,
The theoretical plan of the UK scheme was to screen all sexually-active women from 35 years upwards, and this was a prudent and sensible use of the embryo laboratory services in the mid-1960s, to catch the accumulative prevalence rate of pre-invasive disease which peaks between 35 and 45 years of age. Both dedicated cytology and Well Woman clinics and general practitioners were to act as the main collectors, but also such smears could be taken at any maternity, gynaecological, family planning, or other clinic. The latter sources of smear, combined with the great enthusiasm of the young, and a lack of initiative by the Government to attract the older women, resulted in more than 55% of the smears received by our laboratories coming from the 6-7 million women under 35 years, while the remaining 45% came from nearly double that number of women over 35. The result was that almost 70-80% of the young women must have been screened, but only around 30% of the older women could have been tested. The consequence of this is to be seen in the age-specific death rates", A 50% drop in mortality occurred in the 35-44 year and the 45-54 year age groups in the 10-15 years subsequent to the high concentration of tests on those women who were in the 25-34 cohort 10-15 years before". In effect it was the opportunistic smear collection that achieved this drop, and this was in direct contrast to Government policy. We were promised the age/sex registers by which we could achieve a full call and recall in 1968, when I was on the Central Gynaecological Cytology Committee, but it took 20 years and a lot of work, money and lives before this appeared. It is a moot point as to whether even this structure of formal call and recall by letter is having success throughout the country, as there are reports of 40% or even 20% response rates in urban centres, and this is causing deep concern to those attempting to make this present situation work", Another example of opportunistic screening is that carried out by Elizabeth Hudson and her colleagues in Northwick Park Hospital, where she managed to get a 50% response to an invitation to patients in hospital for some other condition to have a smear taken. The result was that 2296 patients were tested and showed that 5.7 per thousand had serious uterine pathology, and 20 per thousand had significant cytological abnormality (dyskaryosis of all grades & Spencer with lists of clinics throughout the country. They soon found, however, that they were swamping the embryo services, and decided to collect the tests by their Industrial Medical Officers in house. They soon found, also, that a very patchy laboratory service existed at that time, and decided to create a central laboratory service, and in fact built my laboratory at St Stephens Hospital and provided funds for senior technicians, laboratory aids and clerical staff to cope with this work. They now have over 85% of their employees screened either in house, or by the Health Service (the employees have a choice of either) and they are also provided with a full medical examination, and mammographic and clinical breast screening, from the age of 45 years. There is a very high degree of follow-up -even after retirement from their service if desired -and a low labour turnover, and should be considered a substantial support to the health care in this country.
Marks & Spencer carried out a survey of other industrial firms for like initiatives, and of those responding, 40% were supporting in-house collection to some degree, with the smears being read by the Health Service laboratories. Since that time there has been a substantial rise in such commercial programmes, many through the initiative of the Women's National Cancer Control Campaign, and all those smear test results should have been accumulating in the Family Practitioner Committee's (FPCs) age/sex registers to the benefit of the National Screening Programme 7 • I come finally to the Women's National Cancer Control Campaign, which began before the National Screening Programme got off the ground, and probably hastened its inception. I was their medical adviser from the foundation 25 years ago, and am now Chairman of a 20-strong Medical Advisory Committee made up of consultant gynaecologists, cytopathologists, surgeons, community health physicians, general practitioners, epidemiologists, cancer research specialists and doctors who are heavily engaged in smear clinics, both in the Health Service and in our seven Mobile Clinics which traverse the country. At first we were able to offer publicity, education and screening programmes to the District Health Authorities in the country. The service was very heavily used and successful. The Campaign's mobile clinics managed to attract a higher proportion of those at greater risk, that is the over 35s, the lower social classes and those having their first smear. An illustration of this is given in Table 2 . Here it will be seen that in a successive three-year visit of one of our mobile clinics in Birmingham, placed in shopping centres and housing estates, there was a third to a half as many women from the higher risk categories attending our mobile clinics compared to the local statutory clinics. Of course, there was publicity before the mobile clinic arrived, and the throughput of those clinics was 25-30 per session, compared with the 15 or so in the statutory clinics. The latter benefited, however, from that preliminary publicity and the stimulus of the clinic itself in the neighbourhood, which increased attendance in statutory clinics in subsequent months. Another feature shown up in these tables is the tailing-off of the beneficial effects of the mobile clinic in getting at the high-risk population, which may mean there is either a loss of stimulus on repetition of the procedure, or that that population had been adequately screened.
As a result of the first reorganization of the Health Service in 1974, when the Medical Officers of Health were dismantled, the community physicians struggled to find an identity, and the campaign found decreasing support in the District Health Authorities, we attended to the demand which was increasing from industry and from the civil and military services, colleges, universities and trades unions, who were agitating for a better service. We then began to comply with this industrial demand as they provided the financial support for the collection of the smears either in our mobile clinics or in their own medical centres. We arranged for the smears to be examined in the local laboratories, or if they were under pressure, we had a number of larger laboratories able to take on some extra load. It is only latterly, since the second reorganization in 1982 and the endeavours to get the Family Planning Committees' age/sex register off the ground, that there has been any sort of conflict of purpose. Each district appears to have a different policy of age range and frequency, and my laboratory and one or two others are still accepting smears rejected by other laboratories where the smear is from a woman of an age different from their rigidly defined age bracket, or of frequency designed by their cool calculation of workload. Some of these smears contain dyskaryotic cells that need attention.
Both the Community Units and the Laboratories expect to be paid for the screening of their own population if it comes from an industrial or other initiative, even though the cost of collection, which is three to four times that of examining the smear, is being paid for by the industry. This would result in the laboratories being paid twice for the same service, a feature of the new management's approach of making money on any pretext. If the technician's pay was increased this would be justified, but this is not their aim. I have spoken at length on this aspect, as there is a tremendous enthusiasm and goodwill in the population, and the WNCCC has harnessed this better than any other body. It is still running a vigorous publicity, education and screening programme, and all this voluntary work improving the screened status of the population. What is forgotten by the Statutory Health Authorities is that this country's population does not conform to authority as in some other countries in Europe, and we pride ourselves on this individuality. There are differing herd groups in our womenfolk, if I may use such an expression, and differing motivations and responses, and no single approach is going to work. The Campaign has long realized this, and spreads its net of education, publicity and methods of approach to screening in order to catch them all. It has always been said that the general practitioner was the best motivator for the woman to be screened, but now it is becoming the woman's sister or neighbour, and it is here that the Cancer Campaign is achieving success. It would be a great pity if we were to have to wait a further 5 to 10 years to prove that the official form of call and recall does or does not work, with a consequent loss of more lives. It is all too simple for the FPC computers to monitor each new entry smear updating a woman's screened status as coming from an official call or recall initiative, or opportunistically, and still be able to work out their formal approach response in that population. Opportunistic smears are bound to be collected, free of cost to the Health Service, from all the sources mentioned above, and it would be folly not to harness them into the Statutory Screening Programmes in this country, and make the most of their gratuitous and valuable modes Journal of the Royal Society of Medicine Volume 83 May 1990 321 of approach to encourage every woman in this country to have a smear", Finally, as a positive note for the future, while considering the more purpose-built screening clinics and formal invitation to which our population is bound to respond better as time goes on, it should only be a matter of time before cervical screening and breast screening are offered at the same clinic, and ultimately this might expand to skin and colon checks, and even ovary as well. It is then that a formal programme of health check screening would come into its own, and become economic and worthwhile, and would then have a greater appeal to the woman herself.
